Description
Ixazomib citrate is a citrate salt that is a second generation proteasome inhibitor used for anti-cancer research. In vivo research has shown ixazomib citrate to hydrolyze into its active ixazomib form which reversibly inhibits 20S proteasomes in multiple myeloma cancer cells. Ceasing this enzyme’s activity has been shown to decrease angiogenesis, induce apoptotic pathways and upregulate tumor suppressor genes.
Product Specifications
Ixazomib citrate
Formula: C20H23BCl2N2O9
MW: 517.12 g/mol
Storage/Handling: Store at 4°C.
PubChem Chemical ID: 56844015
